APA (7th ed.) Citation

Bini, C., Marcellusi, A., Rotundo, M., D'ambrosio, F., & Mennini, F. (2019). PMH33 COST-UTILITY OF LURASIDONE VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH SCHIZOPHRENIA IN ITALY. Value in Health, 22, S686. https://doi.org/10.1016/j.jval.2019.09.1507

Chicago Style (17th ed.) Citation

Bini, C., A. Marcellusi, M. Rotundo, F. D'ambrosio, and F.S Mennini. "PMH33 COST-UTILITY OF LURASIDONE VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH SCHIZOPHRENIA IN ITALY." Value in Health 22 (2019): S686. https://doi.org/10.1016/j.jval.2019.09.1507.

MLA (9th ed.) Citation

Bini, C., et al. "PMH33 COST-UTILITY OF LURASIDONE VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH SCHIZOPHRENIA IN ITALY." Value in Health, vol. 22, 2019, p. S686, https://doi.org/10.1016/j.jval.2019.09.1507.